tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
ADC Therapeutics Updates Strategic Focus on ZYNLONTA
PremiumCompany AnnouncementsADC Therapeutics Updates Strategic Focus on ZYNLONTA
19d ago
ADC Therapeutics Earnings Call: Growth Amid Challenges
Premium
Company Announcements
ADC Therapeutics Earnings Call: Growth Amid Challenges
2M ago
ADC Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
ADC Therapeutics Reports Q2 2025 Financial Results
2M ago
ADC Therapeutics falls -4.6%
PremiumThe FlyADC Therapeutics falls -4.6%
4M ago
ADC Therapeutics announces new data from Phase 2 trial of Zynlonta
Premium
The Fly
ADC Therapeutics announces new data from Phase 2 trial of Zynlonta
4M ago
ADC Therapeutics price target raised to $10 from $7 at Guggenheim
Premium
The Fly
ADC Therapeutics price target raised to $10 from $7 at Guggenheim
4M ago
ADC Therapeutics falls -4.5%
PremiumThe FlyADC Therapeutics falls -4.5%
5M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
ADC Therapeutics’ Earnings Call: Clinical Wins Amid Challenges
Premium
Company Announcements
ADC Therapeutics’ Earnings Call: Clinical Wins Amid Challenges
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100